Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
<p>Cisplatin resistant HNSCC cells migrate faster than their Cisplatin sensitive counterparts.</p>
Tallennettuna:
| Päätekijä: | |
|---|---|
| Muut tekijät: | , , , , , , , , , , , , , , , , , |
| Julkaistu: |
2025
|
| Aiheet: | |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
| _version_ | 1849927632860217344 |
|---|---|
| author | Abdullah A. Osman (15056323) |
| author2 | Emre Arslan (15056326) Mason Bartels (15056329) Chieko Michikawa (15056332) Antje Lindemann (15056335) Katarzyna Tomczak (15056338) Wangjie Yu (15056341) Vlad Sandulache (15056344) Wencai Ma (15056347) Li Shen (14959241) Jing Wang (14959256) Anand K. Singh (15056350) Mitchell J. Frederick (14959253) Nakia D. Spencer (15056353) Jeffery Kovacs (15056356) Timothy Heffernan (15056359) William F. Symmans (15056362) Kunal Rai (15056365) Jeffrey N. Myers (15026901) |
| author2_role | author author author author author author author author author author author author author author author author author author |
| author_facet | Abdullah A. Osman (15056323) Emre Arslan (15056326) Mason Bartels (15056329) Chieko Michikawa (15056332) Antje Lindemann (15056335) Katarzyna Tomczak (15056338) Wangjie Yu (15056341) Vlad Sandulache (15056344) Wencai Ma (15056347) Li Shen (14959241) Jing Wang (14959256) Anand K. Singh (15056350) Mitchell J. Frederick (14959253) Nakia D. Spencer (15056353) Jeffery Kovacs (15056356) Timothy Heffernan (15056359) William F. Symmans (15056362) Kunal Rai (15056365) Jeffrey N. Myers (15026901) |
| author_role | author |
| dc.creator.none.fl_str_mv | Abdullah A. Osman (15056323) Emre Arslan (15056326) Mason Bartels (15056329) Chieko Michikawa (15056332) Antje Lindemann (15056335) Katarzyna Tomczak (15056338) Wangjie Yu (15056341) Vlad Sandulache (15056344) Wencai Ma (15056347) Li Shen (14959241) Jing Wang (14959256) Anand K. Singh (15056350) Mitchell J. Frederick (14959253) Nakia D. Spencer (15056353) Jeffery Kovacs (15056356) Timothy Heffernan (15056359) William F. Symmans (15056362) Kunal Rai (15056365) Jeffrey N. Myers (15026901) |
| dc.date.none.fl_str_mv | 2025-11-25T13:12:28Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30708198 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/figure/Supplementary_Figure_S1_from_Dysregulation_and_Epigenetic_Reprogramming_of_NRF2_Signaling_Axis_Promote_Acquisition_of_Cisplatin_Resistance_and_Metastasis_in_Head_and_Neck_Squamous_Cell_Carcinoma/30708198 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Cancer Risk Factors Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Drug Resistance Drug Targets Epigenetics Epigenomics Head, Neck & Oral Cancers Preclinical Models Progression, Invasion & Metastasis Tumor progression Small Molecule Agents |
| dc.title.none.fl_str_mv | Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| dc.type.none.fl_str_mv | Image Figure info:eu-repo/semantics/publishedVersion image |
| description | <p>Cisplatin resistant HNSCC cells migrate faster than their Cisplatin sensitive counterparts.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_f424269aab6a7a31d2ee5b67d4d1dc4b |
| identifier_str_mv | 10.1158/1078-0432.30708198 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30708198 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell CarcinomaAbdullah A. Osman (15056323)Emre Arslan (15056326)Mason Bartels (15056329)Chieko Michikawa (15056332)Antje Lindemann (15056335)Katarzyna Tomczak (15056338)Wangjie Yu (15056341)Vlad Sandulache (15056344)Wencai Ma (15056347)Li Shen (14959241)Jing Wang (14959256)Anand K. Singh (15056350)Mitchell J. Frederick (14959253)Nakia D. Spencer (15056353)Jeffery Kovacs (15056356)Timothy Heffernan (15056359)William F. Symmans (15056362)Kunal Rai (15056365)Jeffrey N. Myers (15026901)CancerCancer Risk FactorsTumor BiologyMolecular and Cellular BiologyTherapeutic Research and DevelopmentMethods and TechnologyDrug ResistanceDrug TargetsEpigeneticsEpigenomicsHead, Neck & Oral CancersPreclinical ModelsProgression, Invasion & MetastasisTumor progressionSmall Molecule Agents<p>Cisplatin resistant HNSCC cells migrate faster than their Cisplatin sensitive counterparts.</p>2025-11-25T13:12:28ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30708198https://figshare.com/articles/figure/Supplementary_Figure_S1_from_Dysregulation_and_Epigenetic_Reprogramming_of_NRF2_Signaling_Axis_Promote_Acquisition_of_Cisplatin_Resistance_and_Metastasis_in_Head_and_Neck_Squamous_Cell_Carcinoma/30708198CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307081982025-11-25T13:12:28Z |
| spellingShingle | Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma Abdullah A. Osman (15056323) Cancer Cancer Risk Factors Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Drug Resistance Drug Targets Epigenetics Epigenomics Head, Neck & Oral Cancers Preclinical Models Progression, Invasion & Metastasis Tumor progression Small Molecule Agents |
| status_str | publishedVersion |
| title | Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| title_full | Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| title_fullStr | Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| title_full_unstemmed | Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| title_short | Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| title_sort | Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| topic | Cancer Cancer Risk Factors Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Drug Resistance Drug Targets Epigenetics Epigenomics Head, Neck & Oral Cancers Preclinical Models Progression, Invasion & Metastasis Tumor progression Small Molecule Agents |